Pages that link to "Q37422510"

The following pages link to The rs5743836 polymorphism in TLR9 confers a population-based increased risk of non-Hodgkin lymphoma (Q37422510):

Displaying 23 items.

• Global Plant Stress Signaling: Reactive Oxygen Species at the Cross-Road (Q26768522) ‎ (← links)
• The TLR9 gene polymorphisms and the risk of cancer: evidence from a meta-analysis (Q31131769) ‎ (← links)
• Trial Watch: Toll-like receptor agonists in oncological indications (Q33878578) ‎ (← links)
• The C allele of rs5743836 polymorphism in the human TLR9 promoter links IL-6 and TLR9 up-regulation and confers increased B-cell proliferation (Q34088209) ‎ (← links)
• TLR9 -1486T/C and 2848C/T SNPs Are Associated with Human Cytomegalovirus Infection in Infants (Q35996996) ‎ (← links)
• Involvement of Toll-like Receptor 9 polymorphism in cervical cancer development (Q36060845) ‎ (← links)
• TLR9 agonists induced cell death in Burkitt's lymphoma cells is variable and influenced by TLR9 polymorphism (Q36071989) ‎ (← links)
• Inherited Inflammatory Response Genes Are Associated with B-Cell Non-Hodgkin's Lymphoma Risk and Survival (Q36137122) ‎ (← links)
• Toll-like receptors and human disease: lessons from single nucleotide polymorphisms (Q36382348) ‎ (← links)
• Polymorphism in the promoter region of the Toll-like receptor 9 gene and cervical human papillomavirus infection (Q37111066) ‎ (← links)
• Association between TLR-9 polymorphisms and colon cancer susceptibility in Saudi Arabian female patients (Q37527855) ‎ (← links)
• TLR9 gene polymorphism (rs187084, rs352140): association with acute rejection and estimated glomerular filtration rate in renal transplant recipients (Q38449562) ‎ (← links)
• Inherited variation in immune response genes in follicular lymphoma and diffuse large B-cell lymphoma (Q38516259) ‎ (← links)
• Toll-like receptors targeting technology for the treatment of lymphoma (Q38948266) ‎ (← links)
• Toll-like receptor 2 and 9 genetic polymorphisms and the susceptibility to B cell Non-Hodgkin Lymphoma in Egypt. (Q39378247) ‎ (← links)
• Variations in genes involved in regulation of the nuclear factor - κB pathway and the risk of acute myeloid leukaemia (Q40885153) ‎ (← links)
• Trial Watch: Toll-like receptor agonists for cancer therapy (Q42969291) ‎ (← links)
• Discovery and application of immune biomarkers for hematological malignancies. (Q47681393) ‎ (← links)
• B Cell Lymphoma Immunotherapy Using TLR9-Targeted Oligonucleotide STAT3 Inhibitors (Q50056654) ‎ (← links)
• TLR9 Polymorphisms Might Contribute to the Ethnicity Bias for EBV-Infected Nasopharyngeal Carcinoma (Q90369286) ‎ (← links)
• Functional Polymorphisms and Gene Expression of TLR9 Gene as Protective Factors for Nasopharyngeal Carcinoma Severity and Progression (Q92314002) ‎ (← links)
• TLR4 896A/G and TLR9 1174G/A polymorphisms are associated with the risk of infectious mononucleosis (Q98205267) ‎ (← links)
• CD markers polymorphisms as prognostic biomarkers in hematological malignancies (Q98386581) ‎ (← links)